Specific Use-result Surveillance of Spiriva Respimat in Asthmatics

Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma

NCT02182505 ·Status: COMPLETED ·Phase: PHASE3

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

NCT01424813 ·Status: COMPLETED ·Phase: PHASE3

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids

NCT01458912 ·Status: WITHDRAWN ·Phase: PHASE2

Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone

NCT01458886 ·Status: WITHDRAWN ·Phase: PHASE2

Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants

NCT02495168 ·Status: COMPLETED ·Phase: PHASE3

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy

NCT01397162 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

NCT01634113 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5

NCT00652002 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics

NCT01747629 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5

NCT00651651 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma

NCT02528214 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma

NCT01257230 ·Status: COMPLETED ·Phase: PHASE3

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

NCT01218009 ·Status: TERMINATED ·Phase: PHASE3

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

NCT02980133 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

NCT02181335 ·Status: COMPLETED ·Phase: PHASE3

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg

NCT02091986 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

NCT01634139 ·Status: COMPLETED ·Phase: PHASE3

A 6 Months NIS to Evaluate the Use of Rescue Medication and Quality of Life in Adult Asthmatic Subjects Treated With Symbicort® SMART®

NCT00884689 ·Status: COMPLETED

Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg

NCT00242775 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT

NCT00646321 ·Status: COMPLETED ·Phase: PHASE3

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

NCT01396278 ·Status: TERMINATED ·Phase: PHASE2

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

NCT00252863 ·Status: COMPLETED ·Phase: PHASE3

Fed Study of Albuterol Sulfate Extended-Release Tablets 8 mg and VoSpire® ER Tablets 8 mg

NCT00649987 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.

NCT02149199 ·Status: COMPLETED ·Phase: PHASE3

Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers

NCT05689983 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2